Oregon Public Employees Retirement Fund cut its stake in CVS Health Corporation (NYSE:CVS) by 54.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 112,793 shares of the pharmacy operator’s stock after selling 137,401 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CVS Health Corporation were worth $10,037,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Acrospire Investment Management LLC increased its position in shares of CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 900 shares during the last quarter. MU Investments Co. Ltd. increased its position in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares during the last quarter. Pinkerton Retirement Specialists LLC increased its position in shares of CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares during the last quarter. D Orazio & Associates Inc. increased its position in shares of CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock valued at $111,000 after buying an additional 100 shares during the last quarter. Finally, Cantab Capital Partners LLP increased its position in shares of CVS Health Corporation by 355.4% in the second quarter. Cantab Capital Partners LLP now owns 1,184 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 924 shares during the last quarter. 80.44% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.97% on Monday, hitting $74.78. 8,577,219 shares of the stock traded hands. The stock’s 50 day moving average price is $81.80 and its 200 day moving average price is $91.85. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $106.67. The stock has a market cap of $79.75 billion, a P/E ratio of 16.03 and a beta of 0.88.

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.57 by $0.07. The firm earned $44.60 billion during the quarter, compared to analyst estimates of $45.29 billion. CVS Health Corporation had a net margin of 2.96% and a return on equity of 17.18%. The business’s revenue was up 15.5% on a year-over-year basis. During the same quarter last year, the business earned $1.28 EPS. On average, equities analysts expect that CVS Health Corporation will post $5.81 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th were issued a $0.425 dividend. The ex-dividend date was Thursday, October 20th. This represents a $1.70 annualized dividend and a dividend yield of 2.28%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 36.40%.

COPYRIGHT VIOLATION NOTICE: “Oregon Public Employees Retirement Fund Has $10,037,000 Stake in CVS Health Corporation (CVS)” was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2016/11/28/oregon-public-employees-retirement-fund-has-10037000-stake-in-cvs-health-corporation-cvs.html.

A number of analysts have recently issued reports on the stock. Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Argus reaffirmed a “buy” rating and set a $85.00 price objective (down from $120.00) on shares of CVS Health Corporation in a report on Thursday, November 10th. Zacks Investment Research raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. FBR & Co reaffirmed an “outperform” rating and set a $120.00 price objective on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Morgan Stanley reaffirmed a “hold” rating and set a $104.00 price objective on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.